We’re busy working on the next Digest but in the meantime have a look at the latest Digest for new Top Picks, inexpensive quality stocks and COVID-19 ideas.

One of our ideas in the new Capital Ideas Digest jumped 28% yesterday after updating the market on its development of a COVID-19 antigen test.

Access the new Capital Ideas Digest for investment ideas related to COVID-19, quality stocks at cheap prices and an overhauled, post-crash Top Picks list.

Today’s Digest hi-lights two companies thrust into the crisis spotlight with both having lots of upside. Plus, quality stocks at cheap prices, and revamped top picks.

Tomorrow’s Digest looks at a company whose products assist in the recovery of COVID-19 patients. Plus, research on quality stocks at cheap prices. And two new podcasts.

The Morning Note will not be published tomorrow and will return Monday, April 13. Enjoy the long weekend! Add the latest Digest to your reading list for investment ideas.

The new Digest is available and hi-lights research on a company whose stock could have 120% upside thanks to a “landmark” supply contract to fight COVID-19.

Institutional investors are as bullish as they’ve been in two years. Today’s new Digest tells you why. Plus, a “landmark” contract gives this stock 120% upside.